Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

del Carmen Vennera Maria; Valero Antonio; Uria Estefany; Forne Carles; Picado Cesar

首页> 外文期刊>Clinical drug investigation >Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

【24h】

Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

机译：奥马珠单抗治疗重度持续性哮喘的成本效果分析在西班牙的实际临床实践中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Omalizumab is a humanized monoclonal antibody that targets circulating immunoglobulin E molecules to treat severe uncontrolled asthma. The aim of this study was to determine the cost effectiveness of omalizumab compared with standard treatment for the control of severe persistent asthma according to data from patients treated in a specialized asthma unit.

机译：Omalizumab是一种人源化单克隆抗体，靶向循环免疫球蛋白E分子，可治疗严重的不受控制的哮喘。这项研究的目的是根据在专门的哮喘病部门接受治疗的患者的数据确定与标准疗法相比，奥马珠单抗在控制严重持续性哮喘方面的成本效益。

著录项

来源
《Clinical drug investigation》 |2016年第7期|共12页
作者
del Carmen Vennera Maria; Valero Antonio; Uria Estefany; Forne Carles; Picado Cesar;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain [J] . del Carmen Vennera Maria, Valero Antonio, Uria Estefany, Clinical drug investigation . 2016,第7期

机译：奥马珠单抗治疗重度持续性哮喘的成本效果分析在西班牙的实际临床实践中
2. Optimizing the Position and Use of Omalizumab for Severe Persistent Allergic Asthma Using Cost-Effectiveness Analysis [J] . Faria Rita, McKenna Claire, Palmer Stephen Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2014,第8期

机译：使用成本效果分析优化奥马珠单抗在重度持续性哮喘中的位置和使用
3. ESTIMATING THE IMPACT ASSOCIATED TO THE USE OMALIZUMAB IN THE TREATMENT OF SEVERE PERSISTENT ALLERGIC ASTHMA IN PORTUGAL EVALUATING OUTCOMES AND TREATMENT COSTS USING REAL WORLD DATA FROM PORTUGUESE PATIENTS [J] . Moital I, Carrasco J., Cardoso I, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：使用葡萄牙患者的真实世界数据，评估使用奥马利珠单抗在葡萄牙评估严重持续性过敏性哮喘的效果和治疗费用时的效果
4. Towards a Clinical Practice Guideline Implementation for Asthma Treatment [C] . Francisco Javier Sobrado, Juan Manuel Pikatza, Iker Unai Larburu, Conference on the Spanish association for artificial intelligence . 2004

机译：探讨哮喘治疗的临床实践指南实施
5. Asthma Clinical Practice Guideline Implementation and Evaluation in a Military Treatment Facility Pediatric Clinic. [D] . Jacknewitz-Woolard, Jane E. 2012

机译：军事治疗设施儿科诊所的哮喘临床实践指南实施和评估。
6. Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study [O] . Luis Manuel Entrenas Costa, Francisco Casas-Maldonado, José Gregorio Soto Campos, 2019

机译：严重持续性哮喘患者的奥马珠单抗附加疗法的经济影响和临床结果：一项现实世界研究
7. Investigating The Value Of Omalizumab In The Treatment Of Severe Persistent Allergic Asthma: A Systematic Review Of Cost-Effectiveness Studies [O] . N Likhar, R Kanukula, RK Mothe, 2016

机译：调查omalizumab在严重持续过敏性哮喘治疗中的价值：对成本效益研究的系统综述

Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

摘要

著录项

相似文献

相关主题

期刊订阅